CIK 0001604191 · Non-accelerated filer<br>Smaller reporting company
GridAI Technologies Corp.
Sign in to watch- Ticker
- GRDX
- Exchange
- Nasdaq
- Industry
- Electric & Other Services Combined
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464993860
- Phone
- 561-589-7020
- Business address
- 433 PLAZA REAL, SUITE 275, BOCA RATON, FL
- Former names
- Entero Therapeutics, Inc., First Wave BioPharma, Inc., AzurRx BioPharma, Inc., BioPharma d'Azur, Inc.
- 4 Open-market sale Chief Financial Officer sold 727 shares at $0.64 ($465)
- 4 Open-market sale Chief Financial Officer sold 476 shares at $0.45 ($212)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 621 shares at $1.07 ($664)
- 4 Open-market sale Chairman and CEO sold 1,289 shares at $1.07 ($1,379)
- 4 Grant or award Director acquired 24,889 shares (grant or award)
- 4 Open-market sale Chairman and CEO sold 174 shares at $4.23 ($736)
- 4 Open-market sale Chief Financial Officer sold 75 shares at $4.23 ($317)
- 4 Open-market sale Chairman and CEO sold 1,887 shares at $4.96 ($9,360)
- 4 Open-market sale Chief Financial Officer sold 1,120 shares at $4.96 ($5,555)
- 4 Grant or award President & COO acquired 15,400 shares (grant or award)
- 4 Grant or award Director acquired 440 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 98 shares at $4.20 ($412)
- 4 Open-market sale Chairman, President and CEO sold 166 shares at $4.20 ($697)
- 4 Grant or award Director acquired 19,633 shares (grant or award)
- 4 Grant or award Director acquired 19,633 shares (grant or award)
- 4 Grant or award Director acquired 19,633 shares (grant or award)
- 4 Grant or award Director acquired 19,633 shares (grant or award)
Page 2 of 10 · 181 filings